Global
中文
EN
About
Development milestones
Mission&Vision
Founder
Research Achievement
Technology Platforms
Single domain antibody
Five core technology platforms
Pipeline
Business cooperation
Product Out-Licensing
Co-Development
Career development
Our Story
Social Recruitment
News
Company News
Media
Contact Us
Company Address
Online Message
×
Home
中文
EN
About
About Novamab
Technology Platforms
Pipeline
Business cooperation
Market target layout
Strategic Cooperation
Career development
News
Company News
Media
Contact Us
Our Story
Share the latest information
Our Story
News
Company News
Media
2024-12-19
Novamab has been listed on the 2024 Cyzone 100 Future Unicorn List
More
2021-12-31
Dr. Wan Yakun, founder of Novamab, was successfully selected as "Zhangjiang Outstanding Talent in 2021"!
More
2021-11-29
Novamab announced that its LQ036 (recombinant anti-IL-4Ra single-domain antibody aerosol) was accepted by IND!
More
2021-10-18
The fourth anniversary celebration of Novamab was successfully held!
More
2021-10-11
Novamab announced that its anti-IL-4R sdAb LQ036 clinical phase I study completed the first subject administration!
More
2021-06-29
Novamab has been recognized as a pilot patent enterprise in Shanghai!
More
2021-04-08
Novamab has obtained tens of millions of A+rounds of financing!
More
2021-03-12
Novamab has completed a round of financing of billion yuan!
More
2021-03-08
Rocky Biology has obtained the high-tech enterprise certificate!
More
2020-12-08
Novamab won two honors!
More
2020-10-16
We will work together and forge ahead - the third anniversary of the founding of Novamab
More
总计 47
1
2
3
4
5